| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 免疫系统用药(元) | 59,600,300.22 | 149,341,780.05 | 75,676,074.80 | 169,446,937.34 | 100,824,930.92 |
| 神经系统用药(元) | 49,542,395.20 | 41,915,123.96 | 19,905,253.56 | 55,791,757.17 | 34,971,571.57 |
| 心脑血管用药(元) | 84,782,660.85 | 220,103,668.96 | 116,755,907.69 | 247,503,871.90 | 129,954,762.53 |
| 其他(元) | 2,875,817.33 | 5,121,216.66 | 2,499,682.73 | 3,827,015.30 | 6,286,499.07 |
| 营业成本(元) | |||||
| 免疫系统用药(元) | 19,532,168.49 | 57,404,327.20 | 29,182,470.67 | 60,132,284.65 | 28,147,037.78 |
| 神经系统用药(元) | 26,416,489.96 | 21,643,299.78 | 11,780,890.03 | 27,702,405.95 | 16,616,236.38 |
| 心脑血管用药(元) | 20,721,799.96 | 55,119,860.83 | 30,505,618.08 | 50,245,594.60 | 28,648,301.58 |
| 其他(元) | 2,640,284.34 | 6,263,671.98 | 2,533,076.03 | 2,859,029.13 | 3,014,722.60 |
| 毛利(元) | |||||
| 免疫系统用药(元) | 40,068,131.73 | 91,937,452.85 | 46,493,604.13 | 109,314,652.69 | 72,677,893.14 |
| 神经系统用药(元) | 23,125,905.24 | 20,271,824.18 | 8,124,363.53 | 28,089,351.22 | 18,355,335.19 |
| 心脑血管用药(元) | 64,060,860.89 | 164,983,808.13 | 86,250,289.61 | 197,258,277.30 | 101,306,460.95 |
| 其他(元) | 235,532.99 | -1,142,455.32 | -33,393.30 | 967,986.17 | 3,271,776.47 |
| 毛利率(%) | |||||
| 免疫系统用药(%) | 67.23 | 61.56 | 61.44 | 64.51 | 72.08 |
| 神经系统用药(%) | 46.68 | 48.36 | 40.82 | 50.35 | 52.49 |
| 心脑血管用药(%) | 75.56 | 74.96 | 73.87 | 79.70 | 77.96 |
| 其他(%) | 8.19 | -22.31 | -1.34 | 25.29 | 52.04 |
| 收入构成(%) | |||||
| 免疫系统用药(%) | 30.28 | 35.86 | 35.22 | 35.56 | 37.06 |
| 神经系统用药(%) | 25.17 | 10.06 | 9.27 | 11.71 | 12.86 |
| 心脑血管用药(%) | 43.08 | 52.85 | 54.35 | 51.93 | 47.77 |
| 其他(%) | 1.46 | 1.23 | 1.16 | 0.80 | 2.31 |
| 毛利构成(%) | |||||
| 免疫系统用药(%) | 31.43 | 33.30 | 33.01 | 32.57 | 37.15 |
| 神经系统用药(%) | 18.14 | 7.34 | 5.77 | 8.37 | 9.38 |
| 心脑血管用药(%) | 50.25 | 59.77 | 61.24 | 58.77 | 51.79 |
| 其他(%) | 0.18 | -0.41 | -0.02 | 0.29 | 1.67 |